» Articles » PMID: 30804668

Reliability and Usability of a Weighted Version of the Functional Comorbidity Index

Overview
Publisher Dove Medical Press
Specialty Geriatrics
Date 2019 Feb 27
PMID 30804668
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the reliability of a weighted version of the Functional Comorbidity Index (w-FCI) compared with that of the original Functional Comorbidity Index (FCI) and to test its usability.

Patients And Methods: Sixteen physicians collected data from 102 residents who lived in 16 different nursing homes in the Netherlands. A multicenter, prospective observational study was carried out in combination with a qualitative part using the three-step test interview, in which participants completed the w-FCI while thinking aloud and being observed, and were then interviewed afterward. To analyze inter-rater reliability, a subset of 41 residents participated. The qualitative part of the study was completed by eleven elderly care physicians and one advanced nurse practitioner.

Measurements: The w-FCI was composed of the original FCI supplemented with a severity rating per comorbidity, ranging from 0 (disease absent) to 3 (severe impact on daily function). The w-FCI was filled out at baseline by 16 physicians and again 2 months later to establish intra-rater reliability (intraclass correlations; ICCs). For inter-rater reliability, four pairs of raters completed the w-FCI independently from each other.

Results: The ICCs were 0.90 (FCI) and 0.94 (w-FCI) for intra-rater reliability, and 0.61 (FCI) and 0.55 (w-FCI) for inter-rater reliability. Regarding usability of the w-FCI, five meaningful themes emerged from the qualitative data: 1) sources of information; 2) deciding on the presence or absence of disease; 3) severity of comorbidities; 4) usefulness; and 5) content.

Conclusion: The intra-rater reliability of the FCI and the w-FCI was excellent, whereas the inter-rater reliability was moderate for both indices. Based on the present results, a modified w-FCI is proposed that is acceptable and feasible for use in older patients and requires further investigation to study its (predictive) validity.

Citing Articles

Behavioural and psychological factors associated with pre-frailty in community-dwelling adults aged 40 and over: a cross-sectional study.

Brennan T, Lewis L, Gordon S, Prichard I BMC Public Health. 2025; 25(1):956.

PMID: 40069744 PMC: 11895312. DOI: 10.1186/s12889-025-21957-4.


Depression's double-edged impact on body mass index. A hidden catalyst for non-communicable diseases in South Africa's aging population in long-term care facilities.

Naidoo S, Naidoo N PLoS One. 2025; 20(2):e0319188.

PMID: 39946381 PMC: 11825011. DOI: 10.1371/journal.pone.0319188.


Comparative effectiveness of pelvic floor muscle training, mirabegron, and trospium among older women with urgency urinary incontinence and high fall risk: a feasibility randomized clinical study.

Fisher S, Villasante-Tezanos A, Allen L, Pappadis M, Kilic G Pilot Feasibility Stud. 2024; 10(1):1.

PMID: 38178267 PMC: 10765875. DOI: 10.1186/s40814-023-01440-w.


The prognosis of pre-frail chronic obstructive pulmonary disease patients for hospitalizations and mortality depends on their level of functional physical performance.

Medina-Mirapeix F, Bernabeu-Mora R, Gacto-Sanchez M, Montilla-Herrador J, Escolar-Reina P, Sanchez-Martinez M Chron Respir Dis. 2022; 19:14799731221119810.

PMID: 36071021 PMC: 9459488. DOI: 10.1177/14799731221119810.


State of the Art Physiotherapist-Led Approaches to Safe Aging in Place.

Wilson C, Arena S, Boright L Arch Physiother. 2022; 12(1):17.

PMID: 35909181 PMC: 9341110. DOI: 10.1186/s40945-022-00142-5.


References
1.
Extermann M . Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000; 35(3):181-200. DOI: 10.1016/s1040-8428(00)00090-1. View

2.
CRABTREE H, Gray C, Hildreth A, OConnell J, Brown J . The Comorbidity Symptom Scale: a combined disease inventory and assessment of symptom severity. J Am Geriatr Soc. 2000; 48(12):1674-8. DOI: 10.1111/j.1532-5415.2000.tb03882.x. View

3.
Mandelblatt J, Bierman A, Gold K, Zhang Y, Ng J, Maserejian N . Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods. Health Serv Res. 2002; 36(6 Pt 1):1085-107. PMC: 1089280. View

4.
Rozzini R, Frisoni G, Ferrucci L, Barbisoni P, Sabatini T, Ranieri P . Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity. Age Ageing. 2002; 31(4):277-85. DOI: 10.1093/ageing/31.4.277. View

5.
de Groot V, Beckerman H, Lankhorst G, Bouter L . How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003; 56(3):221-9. DOI: 10.1016/s0895-4356(02)00585-1. View